DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 149 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,240,238 | -64.3% | 175,148 | -74.7% | 0.03% | -64.0% |
| Q2 2022 | $9,086,650 | +13.2% | 691,000 | -20.2% | 0.08% | +50.0% |
| Q1 2022 | $8,027,820 | +1355.5% | 866,000 | +1434.0% | 0.05% | +1150.0% |
| Q4 2021 | $551,546 | -58.6% | 56,453 | +44.0% | 0.00% | -60.0% |
| Q3 2021 | $1,331,948 | -76.5% | 39,198 | -74.7% | 0.01% | -72.2% |
| Q2 2021 | $5,669,351 | +19.6% | 154,858 | +46.5% | 0.04% | -14.3% |
| Q1 2021 | $4,740,799 | +326.0% | 105,727 | +442.2% | 0.04% | +366.7% |
| Q4 2020 | $1,112,865 | -16.7% | 19,500 | -25.1% | 0.01% | -40.0% |
| Q3 2020 | $1,336,000 | -33.6% | 26,050 | -22.7% | 0.02% | -37.5% |
| Q2 2020 | $2,012,000 | -20.3% | 33,704 | -45.0% | 0.02% | -14.3% |
| Q1 2020 | $2,524,000 | -11.8% | 61,315 | +33.3% | 0.03% | +27.3% |
| Q4 2019 | $2,863,000 | – | 46,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |